[sixty one] demonstrated which the CRISPR/Cas9 process could precisely target and cleave conserved locations during the HBV genome, creating robust suppression of viral gene expression and replication each in vitro and in vivoThey observed that Cas9-mediated base enhancing is a potential technique to get rid of CHB by completely inactivating integr